Amarin loses patent lawsuit on main drug, shares tumble
Share!
Business Insurance - Mar 31, 2020
Shares of Amarin Corp. plunged nearly 70% on Tuesday after the drugmaker lost a major U.S. patent battle for its heart drug Vascepa, opening the door for generic competition to its main revenue contributor....
Recommended Articles